| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 10-Q |
| 12 Nov 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On November 10, 2026, Onconetix, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”). The matters voted on at the Annual Meeting were: |
| 09 Nov 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
Onconetix, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows: |
| 06 Nov 2026 | CURRENT REPORT |
| 06 Nov 2026 |
8-K: Entry into a Material Definitive Agreement
This First Amendment to the Share Exchange Agreement (this “Amendment”) is made as of November 4, 2026, by and among (i) Onconetix, Inc., a Delaware corporation (“Buyer”), (ii) Realbotix Corp., a company existing under the laws of the Pr... |
| 05 Nov 2026 | SCHEDULE 13G/A |
| 27 Oct 2026 | FORM 425 |
| 26 Oct 2026 |
8-K: Other Events
CINCINNATI, Ohio, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”), today announced that its Board of Directors has approved a one-for-ten (1-for-10) reverse stock split of the Company’s outstanding common... |
| 23 Oct 2026 | CURRENT REPORT |
| 23 Oct 2026 |
8-K: Other Events
On October 22, 2026, Onconetix, Inc. (the “Company”) made an additional advance of $500,000 to Realbotix, LLC (“Realbotix”) pursuant to that certain Grid Promissory Note, dated September 11, 2026 (the “Note”), previously disclosed in the... |
| 23 Oct 2026 | FORM 425 |
| 16 Oct 2026 | FORM ARS |
| 07 Oct 2026 | Proxy statement: annual meeting on November 10, 2026 |
| 17 Sep 2026 | PRELIMINARY PROXY STATEMENT |
| 14 Sep 2026 | CURRENT REPORT |
| 14 Sep 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR ANY U.S. STATE. SECURITIES LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECT... |
| 14 Sep 2026 | FORM 425 |
| 08 Sep 2026 | PROSPECTUS |
| 03 Sep 2026 | EFFECT |
| 03 Sep 2026 | FORM 425 |
Loading...